Patel U J, Grossman R I, Phillips M D, Udupa J K, McGowan J C, Miki Y, Wei L, Polansky M, van Buchem M A, Kolson D
Department of Radiology, Florida Community Imaging Centers, Dunedin, USA.
AJNR Am J Neuroradiol. 1999 Nov-Dec;20(10):1946-50.
Magnetization transfer ratio histogram peak height (MTR-HPH) has been shown to correlate with macroscopic and microscopic brain disease in patients with multiple sclerosis (MS). We studied the changes in MTR-HPH and in Kurtzke's Expanded Disability Status Scale (EDSS) scores over time in a group of patients with relapsing-remitting MS.
Twenty adult patients with relapsing-remitting MS (four men and 16 women) were followed up for a period of 334 to 1313 days. In all, 86 MR imaging studies of the brain were obtained, and MTR-HPH was calculated for each MR examination by using a semiautomated technique. Changes in MTR-HPH were compared between patients over the study's duration. A neurologist specialized in the care of MS patients assessed the EDSS score for each patient as a measure of clinical disability.
Serial MR data showed a subtle but significant decline in MTR-HPH with time. No significant changes in EDSS scores were noted over the same period.
Patients with relapsing-remitting MS have a significant progressive decline in normalized MTR-HPH, which is independent of EDSS score. MTR-HPH measurements can be used to monitor subclinical disease in patients with relapsing-remitting MS over a short time frame of 1 to 4 years. This parameter might be applied in future therapeutic trials to assess its usefulness.
磁化传递率直方图峰值高度(MTR-HPH)已被证明与多发性硬化症(MS)患者的宏观和微观脑部疾病相关。我们研究了复发缓解型MS患者组中MTR-HPH和库尔特克扩展残疾状态量表(EDSS)评分随时间的变化。
对20例复发缓解型MS成年患者(4例男性和16例女性)进行了334至1313天的随访。总共获得了86次脑部MR成像研究,并使用半自动技术为每次MR检查计算MTR-HPH。在研究期间比较了患者之间MTR-HPH的变化。一位专门护理MS患者的神经科医生评估了每位患者的EDSS评分,作为临床残疾的衡量指标。
系列MR数据显示MTR-HPH随时间有细微但显著的下降。同期EDSS评分无显著变化。
复发缓解型MS患者的标准化MTR-HPH有显著的进行性下降,这与EDSS评分无关。MTR-HPH测量可用于在1至4年的短时间内监测复发缓解型MS患者的亚临床疾病。该参数可能在未来的治疗试验中应用,以评估其效用。